These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32318342)

  • 61. Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma.
    Hiltbrunner S; Mannarino L; Kirschner MB; Opitz I; Rigutto A; Laure A; Lia M; Nozza P; Maconi A; Marchini S; D'Incalci M; Curioni-Fontecedro A; Grosso F
    Front Oncol; 2021; 11():660039. PubMed ID: 34249695
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular Fingerprints of Malignant Pleural Mesothelioma: Not Just a Matter of Genetic Alterations.
    Lorenzini E; Ciarrocchi A; Torricelli F
    J Clin Med; 2021 Jun; 10(11):. PubMed ID: 34199544
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Assessment of the Carcinogenicity of Carbon Nanotubes in the Respiratory System.
    Barbarino M; Giordano A
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33804168
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Epigenetic Alterations and Biomarkers for Immune Checkpoint Inhibitors-Current Standards and Future Perspectives in Malignant Pleural Mesothelioma Treatment.
    Yoshikawa Y; Kuribayashi K; Minami T; Ohmuraya M; Kijima T
    Front Oncol; 2020; 10():554570. PubMed ID: 33381446
    [TBL] [Abstract][Full Text] [Related]  

  • 65. DNA Methylation of
    Cugliari G; Catalano C; Guarrera S; Allione A; Casalone E; Russo A; Grosso F; Ferrante D; Viberti C; Aspesi A; Sculco M; Pirazzini C; Libener R; Mirabelli D; Magnani C; Dianzani I; Matullo G
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33233407
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Malignant Pleural Mesothelioma: Genetic and Microenviromental Heterogeneity as an Unexpected Reading Frame and Therapeutic Challenge.
    Abbott DM; Bortolotto C; Benvenuti S; Lancia A; Filippi AR; Stella GM
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32392897
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Circulating Epigenetic Biomarkers in Malignant Pleural Mesothelioma: State of the Art and critical Evaluation.
    Ferrari L; Carugno M; Mensi C; Pesatori AC
    Front Oncol; 2020; 10():445. PubMed ID: 32318342
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Use of Immunohistochemistry, Fluorescence
    Rozitis E; Johnson B; Cheng YY; Lee K
    Front Oncol; 2020; 10():1742. PubMed ID: 33014860
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives.
    Cavallari I; Urso L; Sharova E; Pasello G; Ciminale V
    Front Oncol; 2019; 9():740. PubMed ID: 31475103
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Circulating biomarkers in malignant pleural mesothelioma.
    Viscardi G; Di Natale D; Fasano M; Brambilla M; Lobefaro R; De Toma A; Galli G
    Explor Target Antitumor Ther; 2020; 1(6):434-451. PubMed ID: 36046389
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular markers and new diagnostic methods to differentiate malignant from benign mesothelial pleural proliferations: a literature review.
    Bruno R; Alì G; Fontanini G
    J Thorac Dis; 2018 Jan; 10(Suppl 2):S342-S352. PubMed ID: 29507804
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease.
    Cavalleri T; Angelici L; Favero C; Dioni L; Mensi C; Bareggi C; Palleschi A; Rimessi A; Consonni D; Bordini L; Todaro A; Bollati V; Pesatori AC
    PLoS One; 2017; 12(5):e0176680. PubMed ID: 28472171
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genetic predisposition for malignant mesothelioma: A concise review.
    Betti M; Aspesi A; Sculco M; Matullo G; Magnani C; Dianzani I
    Mutat Res Rev Mutat Res; 2019; 781():1-10. PubMed ID: 31416570
    [TBL] [Abstract][Full Text] [Related]  

  • 74. miR-625-3p and lncRNA GAS5 in Liquid Biopsies for Predicting the Outcome of Malignant Pleural Mesothelioma Patients Treated with Neo-Adjuvant Chemotherapy and Surgery.
    Kresoja-Rakic J; Szpechcinski A; Kirschner MB; Ronner M; Minatel B; Martinez VD; Lam WL; Weder W; Stahel R; Früh M; Cerciello F; Felley-Bosco E
    Noncoding RNA; 2019 Jun; 5(2):. PubMed ID: 31212997
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.